Ashwagandha root vs leaf extract: why the plant part belongs on your spec

Two ashwagandha extracts can carry the same withanolide percentage on the label and still be materially different products. The variable most often left unstated is the plant part.

Root, leaf, or both

Traditional Ayurvedic use of Withania somnifera centres on the root. Leaf material contains withanolides too — often at higher concentrations and at lower cost — which is why some extracts are produced from leaf, or from a root-and-leaf blend.

Neither is inherently wrong. But they are not interchangeable, and the withanolide profile differs between them, not just the total percentage.

Why the total percentage can mislead

"5% withanolides" describes a quantity, not a composition. Two extracts hitting that number from different plant parts, by different methods, will not necessarily behave the same way in your formulation or match the clinical literature you are citing.

If your product claims are anchored to published research, check what material that research used — and specify the same.

What to put on your specification

• Plant part — "root only" if that is what you require, stated explicitly.
• Assay method — withanolides by HPLC, with the reference standard named.
• Extraction — water, hydro-alcoholic, or otherwise, and the carrier if any.
• Extract ratio — where relevant, alongside the standardized assay.

A pricing signal worth noticing

Regulatory treatment of ashwagandha differs between markets and has been reviewed in several jurisdictions in recent years. Before committing to a first order, confirm the current requirements for the market you are selling into rather than relying on what applied a year ago.

And if a quote is notably cheaper than the market at the same stated withanolide percentage, the plant part is the first place to look.